Revolution Medicines's market cap is currently $8.14B. The company's EPS TTM is $-1.31; its P/E ratio is ―; Revolution Medicines is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.41. See an overview of income statement, balance sheet, and cash flow financials.
